Bonus BioGroup Ltd. (TLV:BONS)
21.90
-0.70 (-3.10%)
Oct 28, 2025, 2:31 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 255.78 million as of October 28, 2025. Its market cap has increased by 62.22% in one year.
Market Cap
255.78M
Enterprise Value
264.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
21.90
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 255.78M, an increase of 1,968.95%. That is a compound annual growth rate of 25.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 255.78M | 84.03% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | 483.51M | 29.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 71.30B |
| Danel (Adir Yeoshua) | 3.02B |
| Kamada | 1.30B |
| SofWave Medical | 1.09B |
| BrainsWay | 1.05B |
| Bait Bakfar | 1.04B |
| Ilex Medical | 725.21M |
| Novolog (Pharm-Up 1966) | 662.09M |